Hepatitis C Virus (HCV) Antiviral Market Growth Analysis | 2021-2026

Market Insights

The Hepatitis C Virus (HCV) Antiviral Market was estimated at USD xx billion in 2020 and is likely to grow at a CAGR of x% during 2021-2026 to reach USD xx billion in 2026.

Want to know more about the market scope? Register Here

What is the Hepatitis C Virus (HCV) Antiviral?

Hepatitis C is defined as an infectious disease caused by a virus that affects the liver and leads to inflammation. Based on the product, the hepatitis C virus can be categorized as HCV antibody, HCV viral load, and HCV genotyping.

Covid-19 Impact

The outbreak of COVID-19 significantly impacted the materials supply chains, international trade, and manufacturing operations across the world. The production of hepatitis c virus (HCV) antiviral declined amidst the COVID-19 pandemic as the market players had to shut production facilities or operate the facilities below the optimal production capacities to avoid the spread of the coronavirus.

Key Players

Key players operating in the market are-

• F. Hoffmann-La Roche AG (Switzerland)
• Abbott Laboratories (US)
• Siemens AG (Germany)
• QIAGEN (Germany)
• bioMérieux SA (France)
• Bio-Rad Laboratories, Inc. (US)
• Meridian Bioscience Inc. (US)
• Biogate Laboratories Ltd (Canada)
• J. Mitra & Co. Pvt. Ltd. (India)
• Siemens Healthineers AG (Germany)
• General Biologicals Corporation (Taiwan)

Market Dynamics

The global growth of the hepatitis C virus (HCV) antiviral market size is primarily driven by the rising number of people affected by the hepatitis C virus. Increasing spending on healthcare due to the rising prevalence of diseases and changing lifestyle is expected to add to the market growth substantially. In addition to this, rising investment in R&D activities for the development of new antiviral drugs is likely to create lucrative opportunities for the players operating in the global market during the review period.

Want to have a closer look at this market report? Click Here.

Segment’s Analysis

By End User Type

Based on end users, the hepatitis C virus (HCV) antiviral market has been divided into diagnostic centers, hospitals, and home use. The hospital application segment accounted for the largest market share in 2020. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled healthcare staff.

Regional Insights

By region, the North America Hepatitis C Virus (HCV) Antiviral market accounted for the largest share in 2020 and is expected to grow at a significant CAGR during the review period. The regional market growth can be attributed to the strong presence of the healthcare industry and the presence of key market players such as Abbott Laboratories (US) and Bio-Rad Laboratories, Inc. (US). The market growth in the Asia-Pacific region is expected to grow at the fastest CAGR during the review on account of an increasing number of people suffering from the hepatitis C virus.

Know the high-growth countries in this report. Register Here

Critical Questions Answered in the Report

• What are the key trends in the global market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global market?
• What are the key strategies adopted by the major vendors to lead in the market?
• What is the market share of the top vendors?

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The hepatitis C virus (HCV) antiviral market is segmented into the following categories.

By Product Type

• HCV Antibody
• HCV Viral Load
• HCV Genotyping

By End-User Type

• Diagnostic Centers
• Hospitals
• Home Use

By Region

• North America (Country Analysis: the USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Click Here, to learn the market segmentation details.

Target Audience

The target audience of the Hepatitis C Virus (HCV) Antiviral Market includes-

• Hepatitis C Virus (HCV) Antiviral Vendors
• Hepatitis C Virus (HCV) Antiviral Manufacturers
• Hepatitis C Virus (HCV) Antiviral Distributors
• Organizations
• Government Bodies

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation by any one of the product types by end-user type.

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.